These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22195801)

  • 1. Preparation and evaluation of injectable sustained-release microspheres of rivastigmine.
    Zhu Y; Zhu Z; Cao Q; Chen D; Cui J
    J Control Release; 2011 Nov; 152 Suppl 1():e131-2. PubMed ID: 22195801
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
    Ye L; Fu F; Liu W; Sun K; Li Y; He J; Yu X; Yu P; Tian J
    Pak J Pharm Sci; 2013 Mar; 26(2):315-22. PubMed ID: 23455202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of rivastigmine liposomes for delivery into the brain through intranasal route.
    Arumugam K; Subramanian GS; Mallayasamy SR; Averineni RK; Reddy MS; Udupa N
    Acta Pharm; 2008 Sep; 58(3):287-97. PubMed ID: 19103565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ-forming oleogel implant for rivastigmine delivery.
    Vintiloiu A; Lafleur M; Bastiat G; Leroux JC
    Pharm Res; 2008 Apr; 25(4):845-52. PubMed ID: 17694395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
    Chu DF; Fu XQ; Liu WH; Liu K; Li YX
    Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
    Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
    J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of rivastigmine liposome and its pharmacokinetics in rats after intranasal administration].
    Yang ZZ; Wang ZZ; Wu K; Qi XR
    Yao Xue Xue Bao; 2011 Jul; 46(7):859-63. PubMed ID: 22010358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
    J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
    Liang R; Zhu J
    J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
    Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
    J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A facile way to fabricate polyester microcapsules.
    Yu X; Zhu J
    J Control Release; 2011 Nov; 152 Suppl 1():e128-9. PubMed ID: 22195798
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.